Autologous Matrix-induced Chondrogenesis Market and Factors Behind its Growing Landscape – Industry Analysis by Top Vendors, Size, Growth Factors and Forecast to 2027

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Autologous matrix-induced chondrogenesis is a medical procedure to repair articular cartilage damage and is a one-step process that uses the micro fracturing method, followed by the application of bilayer collagen I/III membrane by partially autologous fibrin glue.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/2748

Market – Drivers

Growing prevalence of bone and joint disorders such as osteoporosis and arthritis, a growing number of sports-related injuries, and increasing demand for minimally-invasive surgery is propelling the market growth of autologous matrix-induced chondrogenesis.

For instance, according to the National Center for Biotechnology Information (NCBI) 2016 report, over 200 million people are suffering from osteoporosis worldwide in 2015. 1 in 3 women over the age of 50 years and 1 in 5 men will experience osteoporosis fractures in their lifetime.

A growing number of surgeries is further projected to fuel the autologous matrix-induced chondrogenesis market growth over the forecast period. For instance, according to the American Academy of Orthopaedic Surgeon (AAOS) 2019 report, around 267,000 knee replacements are performed each year in the U.S.

Market – Restraints

On the flip side, unfavorable reimbursement policies and high cost of cartilage replacement are projected to hinder the growth of the autologous matrix-induced chondrogenesis market. Several health insurance companies do not insure AMIC procedure. For instance, according to Blue Cross Blue Shield of North Carolina 2019, for patients without health insurance, a total hip replacement usually costs between US$ 31,839 and US$ 44,816, with an average cost of US$ 39,299 in the U.S.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2748

Regional Analysis

Based on region, the autologous matrix-induced chondrogenesis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is projected to hold a leading position in the autologous matrix-induced chondrogenesis market over the forecast period, and this can be attributed to increasing sports-related injuries in the region. For instance, according to the National Safety Council (NSC) report, in 2017, over 526,000 sports-related injuries were reported in the U.S.

The Asia Pacific is projected to witness significant growth over the forecast period, due to the growing demand for minimally-invasive surgery in the region. For instance, according to the National Center for Biotechnology Information, in 2017, minimally-invasive surgery was carried out firstly in China. Laparoscopy surgery was one of the first types of minimally-invasive surgery.

Competitive Landscape

Key players operating in the autologous matrix-induced chondrogenesis market include Biotissue AG, Arthro-Kinetics, JRL Orthopaedic Ltd, B Braun, Melsungen AG, Matricel GmbH, Geistlich Pharma AG, and Zimmer Biomet Holdings.

Market – Taxonomy

The global autologous matrix-induced chondrogenesis market is segmented based on material type, application, and region.

By Material Type

• Collagen
• Polyethylene Glycol
• Polylactic-Co-Glycolic Acid
• Hyaluronic Acid

By Application

• Knee Cartilage
• Elbow Cartilage
• Hip Cartilage

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.